PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2015Molecular Cancer379 citationsOpen Access

The role of the insulin-like growth factor-1 system in breast cancer

PCPanagiotis ChristopoulosPMPavlos MsaouelMKMichael Koutsilieris

Key Points

  • This review aims to explore the function and regulation of IGF-1 in breast cancer.
  • Overview of IGF-1 system and its signaling pathways related to breast cancer.
  • Analysis of IGF-1R engagement and its downstream effects on proliferation and apoptosis.
  • IGF-1 promotes proliferation and inhibits apoptosis in breast cancer cells.
  • IGF-1 signaling pathways converge with key pathways involved in breast cancer development.

Abstract

IGF-1 is a potent mitogen of major importance in the mammary gland. IGF-1 binding to the cognate receptor, IGF-1R, triggers a signaling cascade leading to proliferative and anti-apoptotic events. Although many of the relevant molecular pathways and intracellular cascades remain to be elucidated, a growing body of evidence points to the important role of the IGF-1 system in breast cancer development, progression and metastasis. IGF-1 is a point of convergence for major signaling pathways implicated in breast cancer growth. In this review, we provide an overview and concise update on the function and regulation of IGF-1 as well as the role it plays in breast malignancies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Christopoulos et al. (2015) studied this question.

synapsesocial.com/papers/69daa656a6045d71bfa3d7bdhttps://doi.org/10.1186/s12943-015-0291-7
Ask AI
Helpful
Bookmark
Share
View Full Paper